E-cadherin expression in normal and abnormal tissue specimens from patients with pancreatic carcinoma

Laboratory Medicine

Volumn 41, Issue 8, 2010, Pages 473-477

  Fei, Yang ^a   Liu, Xu Shun ^a   Wang, Feng ^a   Wang, Wei ^a   Liu, Sheng Li ^b  

^a The 81st Hospital of PLA   (China)

^b SOUTHEAST UNIVERSITY   (China)

Author keywords

Clinicopathological characteristics; CTNND1; E cadherin; Pancreatic carcinoma; Pathologic tumor node metastasis classification; Prognosis; pTNM

Indexed keywords

CATENIN; CATENIN DELTA 1; UNCLASSIFIED DRUG; UVOMORULIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER INVASION; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CLINICAL FEATURE; DISEASE ASSOCIATION; DISTANT METASTASIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PANCREAS CARCINOMA; PROGNOSIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SURVIVAL RATE; TISSUE DIFFERENTIATION;

EID: 77955739641     PISSN: 00075027     EISSN: 19437730     Source Type: Journal    
DOI: 10.1309/LMXTBGYUXTVMWS61     Document Type: Article

References (19)

1. Lowenfels AB, Maisonneuve P. Risk factors for pancreatic cancer. J Cell Biochem. 2005;95:649-656.
2. Lowenfels AB, Maisonneuve P. Epidemiology and risk factors for pancreatic cancer. Best Pract Res Clin Gastroenterol. 2006;20:197-209.
3. McKenna S, Eatock M. The medical management of pancreatic cancer: A review. Oncologist. 2003;8:149-160. (Pubitemid 36428281)
4. Kim DY, Joo JK, Park YK, et al. E-cadherin Expression in early gastric carcinoma and correlation with lymph node metastasis. J Surg Oncol. 2007;96:429-435. (Pubitemid 47519450)
5. van Oort IM, Tomita K, van Bokhoven A, et al. The prognostic value of E-cadherin and the cadherin-associated molecules alpha-, beta-, gamma-catenin and P120ctn in prostate cancer specific survival: A long-term follow-up study. Prostate. 2007;67:1432-1438. (Pubitemid 47435789)
6. Hu J, Fei Y, Liu XS, et al. The influence of exon 7 Phe389Leu polymorphism on P120 catenin interactions with E-cadherin and three-dimensional model rebuilt. Cell Mol Biol (Noisy-le-grand). 2009;55(suppl OL):1200-7.
7. Christofori G, Semb H. The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem Sci. 1999;24:73-76. (Pubitemid 29346577)
8. Nigam AK, Savage FJ, Boulos PB, et al. Loss of cell-cell and cell-matrix adhesion molecules in colorectal cancer. Br J Cancer. 1993;68:507-514.
9. Reynolds AB. p120-catenin: Past and present. Biochim Biophys Acta. 2007;1773:2-7.
10. Ireton RC, Davis MA, van Hengel J, et al. A novel role for p120 catenin in E-cadherin function. J Cell Biol. 2002;159:465-476.
11. AJCC Cancer Staging Handbook. 5th ed. Philadelphia, PA: Lippincott-Raven; 1997:103.
12. Joo YE, Rew JS, Park CS, et al. Expression of E-cadherin, alpha-and beta-catenins in patients with pancreatic adenocarcinoma. Pancreatology. 2002;2:129-137.
13. Wang EH, Liu Y, Xu HT. Abnormal expression and clinicopathologic significance of P120-catenin in lung cancer. Histol Histopathol. 2006:21:841-847. (Pubitemid 44082726)
14. Oka H, Shiozaki H, Kobayashi K, et al. Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res. 1993;53:1696-1701. (Pubitemid 23113254)
15. Qin Y, Capaldo C, Gumbiner BM, et al. The mammalian Scribble polarity protein regulates epithelial cell adhesion and migration through E-cadherin. J Cell Biol. 2005;171:1061-1071. (Pubitemid 41815837)
16. Thoreson MA, Anastasiadis PZ, Daniel JM, et al. Selective uncoupling of p120(ctn) from E-cadherin disrupts strong adhesion. J Cell Biol. 2000;148:189-202.
17. Jawhari A, Jordan S, Poole S, et al. Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: Relationship with patient's survival. Gastroenterology. 1997;112:46-54. (Pubitemid 27008985)
18. Gabbert HE, Mueller W, Schneiders A, et al. Prognostic value of E-cadherin expression in 413 gastric carcinomas. Int J Cancer. 1996;69:184-189. (Pubitemid 26233296)
19. Ramasami S, Kerr KM, Chapman AD, et al. Expression of CD44v6 but not E-cadherin or beta-catenin influences prognosis in primary pulmonary adenocarcinoma. J Pathol. 2000;192:427-432.